Definition of a new blood cell count score for early survival prediction for non-small cell lung cancer patients treated with atezolizumab: Integrated analysis of four multicenter clinical trials

IMPORTANCE: Blood cell count test (BCT) is a robust method that provides direct quantification of various types of immune cells to reveal the immune landscape to predict atezolizumab treatment outcomes for clinicians to decide the next phase of treatment. OBJECTIVE: This study aims to define a new B...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jian-Guo, Wong, Ada Hang-Heng, Wang, Haitao, Jin, Su-Han, Tan, Fangya, Chen, Yu-Zhong, He, Si-Si, Shen, Gang, Frey, Benjamin, Fietkau, Rainer, Hecht, Markus, Carr, Shamus R., Wang, Ruihong, Shen, Bo, Schrump, David S., Ma, Hu, Gaipl, Udo S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478919/
https://www.ncbi.nlm.nih.gov/pubmed/36119066
http://dx.doi.org/10.3389/fimmu.2022.961926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478919/
https://www.ncbi.nlm.nih.gov/pubmed/36119066
http://dx.doi.org/10.3389/fimmu.2022.961926

Ejemplares similares